MMA Surgery Improves Long-Term Quality of Life for Apnea Patients

Dentistry Today


Surgery that moves the jaws forward can significantly improve long-term quality of life, including functional outcomes and sleep quality, in patients with obstructive sleep apnea (OSA), according to researchers at Allegheny General Hospital in Pittsburgh.

The researchers analyzed long-term quality of life factors in 27 patients who underwent maxillomandibular advancement (MMA), which helps open the airway to treat severe OSA. 

The patients received follow-up examinations for at least five years and for an average of nearly 13 years. They answered a questionnaire that asked about sleep quality, daytime function, and physical, mental, emotional, and sexual health.

Among the results, 88% said they snored less, 82% said their sleep quality improved, and 77% said they experienced less difficulty remaining awake during the day. Also, 76% were satisfied that the MMA managed their OSA, 71% would undergo MMA again to treat their OSA, and 65% would recommend MMA to other OSA patients.

Further, patients said they felt their speech quality or swallowing ability did not change, they experienced bearable pain after surgery, and they had a satisfactory facial appearance.

The researchers said that the most significant subjective improvements were in personal satisfaction, sleep quality, and functional outcomes, indicating that very long-term subjective improvements in quality of life issues from MMA for OSA are possible.

No significant improvements or change occurred in some categories, including physical health and sexual desire, but their results could decrease with age even in those who do not undergo surgery, the researchers said.

The study, “Maxillomandibular Advancement for Obstructive Sleep Apnea Is Associated With Very Long-Term Overall Sleep-Related Quality-of-Life Improvement,” was published by the Journal of Oral and Maxillofacial Surgery.

Related Articles

MMA Proves Effective in Treating Obstructive Sleep Apnea

Children Underdiagnosed for Sleep Disordered Breathing

Sleep Apnea Linked With Alzheimer’s Disease Biomarker